Polyplus
FranceWho owns Polyplus?
Polyplus is a French Biotech company, now owned by Sartorius, which acquired it in 2023 from ARCHIMED and Peugeot Invest.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2023 to Sartorius Stedim.
- ·Best return: 300.0x MOIC by ARCHIMED (2023 exit).
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
2 ownership periods · co-invest detected
ARCHIMED sold Polyplus to Sartorius Stedim in 2023 after 7 years.
Peugeot Invest sold Polyplus to Sartorius in 2023 after 3 years.
More from Direct investment by Peugeot Invest
Other portfolio companies in the same fund.
Germany
US
LuxembourgMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Polyplus?
Polyplus is now owned by Sartorius, which acquired it in 2023 from ARCHIMED and Peugeot Invest.
When did Sartorius acquire Polyplus?
Sartorius acquired Polyplus in 2023, buying from ARCHIMED and Peugeot Invest.
Who did Polyplus sell to?
ARCHIMED sold Polyplus to Sartorius Stedim in 2023 (Trade Sale), 300.0x return. Peugeot Invest sold Polyplus to Sartorius in 2023 (Trade Sale), 3.8x return.
Who has owned Polyplus over time?
Polyplus has been through 2 private-equity ownership periods: ARCHIMED · via MED I · 2016–2023 · sold to Sartorius Stedim · (Trade Sale) · 300.0x; Peugeot Invest · via Direct investment by Peugeot Invest · 2020–2023 · sold to Sartorius · (Trade Sale) · 3.8x.